Rationale
Abnormalities in excitatory/inhibitory neurotransmission are hypothesized to
contribute to autism spectrum disorder (ASD) etiology. BTBR, an inbred mouse strain,
displays social deficits and repetitive self-grooming, offering face validity to ASD
diagnostic symptoms. Reduced GABAergic neurotransmission in BTBR suggests that
GABAA receptor positive allosteric modulators (PAMs) could improve
ASD-relevant BTBR phenotypes. The neuroactive steroid ganaxolone acts as a PAM,
displaying anticonvulsant properties in rodent epilepsy models and an anxiolytic-like
profile in the elevated plus-maze.
Objectives
We evaluated ganaxolone in BTBR and C57BL/6J mice in standardized assays for
sociability and repetitive behaviors. Open field and anxiety-related behaviors were
tested as internal controls and for comparison with the existing neuroactive steroid
literature.
Results
Ganaxolone improved aspects of social approach and reciprocal social
interactions in BTBR, with no effect on repetitive self-grooming, and no detrimental
effects in C57BL/6J. Ganaxolone increased overall exploratory activity in BTBR and
C57BL/6J in the open field, social approach, and elevated plus-maze, introducing a
confound for the interpretation of social improvements. Allopregnanolone and diazepam
similarly increased total entries in the elevated plus-maze, indicating that behavioral
activation may be a general property of GABAA receptor PAMs in these
strains.
Conclusions
Ganaxolone shows promise for improving sociability. In addition, ganaxolone, as
well as other GABAA receptor PAMs, enhanced overall BTBR activity. The
translational implications of specific sociability improvements and non-specific
behavioral activation by ganaxolone in the BTBR model remains to be determined. Future
studies to explore whether PAMs provide a novel profile with unique benefits for ASD
treatment will be worthwhile.